SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-22-001914
Filing Date
2022-01-06
Accepted
2022-01-06 16:16:21
Documents
13
Period of Report
2022-01-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm221865d1_8k.htm   iXBRL 8-K 28598
  Complete submission text file 0001104659-22-001914.txt   247219

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA elan-20220101.xsd EX-101.SCH 3753
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE elan-20220101_def.xml EX-101.DEF 26917
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE elan-20220101_lab.xml EX-101.LAB 37829
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE elan-20220101_pre.xml EX-101.PRE 25526
7 EXTRACTED XBRL INSTANCE DOCUMENT tm221865d1_8k_htm.xml XML 5158
Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Filer) CIK: 0001739104 (see all company filings)

IRS No.: 825497352 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38661 | Film No.: 22515007
SIC: 2834 Pharmaceutical Preparations